CreditReports.dk
HomeScreen companies

MACURE PHARMA ApS Financials, key figures and credit report

CVR number: 35234748 Established 2013 Industry: 46 Wholesale trade
Company contact details
Hejrevej 39, 2400 København NV info@macurepharma.com tel: 70204107
Gross profit 47 649.4 kDKK FY 2025 +22% vs 2024
EBIT 24 824.3 kDKK FY 2025 +5.3% vs 2024
Net debt 64 787.6 kDKK FY 2025 -52% vs 2024
Quick ratio 0.7 FY 2025 -0.1 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit24 981.8738 049.1724 158.8639 051.2347 649.38
Employee benefit expenses-18 271.94-15 743.32-11 353.89-15 044.16-21 628.72
Total depreciation- 153.08- 137.84-1 252.84- 438.23-1 196.38
EBIT6 556.8522 168.0111 552.1423 568.8424 824.28
Other financial income99.75985.183 268.424 239.103 363.39
Other financial expenses- 172.76- 178.03-3 454.51-16 898.70-14 000.98
Pre-tax profit6 483.8522 975.1511 366.0410 909.2414 186.69
Income taxes-1 436.15-5 080.61-2 575.67-2 414.22-3 132.68
Net earnings5 047.7017 894.558 790.388 495.0111 054.00

Assets (kDKK)

2021
2022
2023
2024
2025
Intangible rights2 206.602 571.284 960.359 272.2014 867.55
Intangible assets total2 206.602 571.284 960.359 272.2014 867.55
Buildings683.904 337.27
Tangible assets total683.904 337.27
Investments total146.67167.99169.551 144.751 040.21
Long term receivables total
Raw materials and consumables2 770.881 008.761 549.63
Finished products/goods24 889.1522 219.5023 294.9524 745.4634 509.51
Advance payments214.72238.1495.00
Inventories total24 889.1524 990.3824 518.4226 533.2434 604.51
Current trade debtors52 805.5040 220.0128 790.3644 553.6743 553.44
Current amounts owed by group member comp.10 866.991 674.59
Prepayments and accrued income1 001.00763.551 845.892 197.43
Current other receivables28 636.0167 616.71101 539.7048 037.84
Current deferred tax assets186.39486.17280.3017.13
Short term receivables total63 858.8870 343.2097 450.92147 956.3995 463.29
Cash and bank deposits9 383.6018 487.5643 174.0816 919.6511 888.90
Cash and cash equivalents9 383.6018 487.5643 174.0816 919.6511 888.90
Balance sheet total (assets)100 484.90116 560.40170 273.32202 510.14162 201.73

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital80.0080.0080.0080.0080.00
Shares repurchased5 000.0018 000.007 700.008 000.0011 950.00
Retained earnings372.02-12 580.29-2 385.74-1 595.37-5 050.35
Profit of the financial year5 047.7017 894.558 790.388 495.0111 054.00
Shareholders equity total10 499.7123 394.2614 184.6314 979.6518 033.65
Provisions645.44
Non-current liabilities total
Current loans from credit institutions96.93169.2883.72
Advances received464.7863.30103.69
Current trade creditors27 639.8223 540.2321 298.9927 692.3120 099.41
Current owed to participating21 004.3340.8252.1998.8292.07
Current owed to group member22 216.8562 641.67131 135.00151 495.6976 500.74
Short-term deferred tax liabilities1 370.455 380.392 369.802 151.062 470.11
Other non-interest bearing current liabilities17 753.731 098.261 072.485 819.6544 276.60
Current liabilities total89 985.1893 166.15156 088.69187 530.49143 522.64
Balance sheet total (liabilities)100 484.90116 560.40170 273.32202 510.14162 201.73
Page generated